Drug development: describes the process of developing a new drug that energetically targets a specific weakness in a cell. The process consist of bringing a new pharmaceutical drug to the market once a lead compound has been identified through the process of drug discovery.
-
Genetically engineered cellular models are an integral part of the drug discovery process from early discovery through clinical biomanufacturing. The various applications of these cellular m...
High-throughput sequencing technology such as RNASeq and whole genome sequencing has enabled deep characterization of health and disease states. Biomarker discovery by these means has only h...
The prevalence of NASH in global populations continues to expand in conjunction with the ongoing obesity and diabetes epidemic. Over the next decade, the disease is projected to become the l...
What does a quantum leap in drug development look like and what is necessary to make it happen? Our greatest opportunity to deliver significant increases in the speed and effectiveness of dr...
Interested in learning more about assay design for primers and probes? Join us for this special Guardian of Your Science “Ask the Expert” webinar, hosted by field applications sc...
Date: January 11, 2022 Time: 08:00am (PST), 11:004am (EST) Connectivity of laboratory equipment is progressing rapidly. While it started with the possibility to export data from the equipmen...
Date: December 9, 2021 Time: 6:00am (PDT), 9:00 am (EDT) As the number of biotherapeutic candidates in development is increasing, the requirements of analytical tools to understand the molec...
Date: December 08, 2021 Time: 7:00am (PDT), 10:00am (EDT) Successful bioprocessing is complex and depends on many factors. From the selection of the expression host, media composition, the p...
Date: December 01, 2021 Time: 8:00am (PDT), 11:00am (EDT) Discover how taking a holistic approach can help simplify and improve your cell culture media process workflows. In a discussion wit...
Date: November 30, 2021 Time: 11:00am (PDT), 2:00pm (EDT) In the recent years, measurable residual disease (MRD) assessment on multiple myeloma patients has gained increasing relevance. After...
Date: November 18, 2021 Time: 11:00am (PDT), 2:00pm (EDT) An important lesson learned from the COVID-19 pandemic is how critical the microbiology laboratory is to ensuring hospitals have sur...
Date: November 18, 2021 Time: 9:00am (PDT), 12:00pm (EDT) Therapeutic proteins such as monoclonal antibodies (mAbs) and mAb variants have been successfully applied in the treatment of cancer...